Clinical trial
Randomized Controlled Trial of Spiral Exhalation Device Oxygen Therapy to Improve the Treatment Effect of Patients With Severe Pneumonia.
NCT05452759 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Spiral Exhalation Device Oxygen Therapy to Improve the Treatment Effect of Patients With Severe Pneumonia.
- Lead sponsor
- Shenzhen Second People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2022
- Completion date
- June 30, 2025
- Enrollment
- 156 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.